Janus Henderson Group
HRMY icon

Janus Henderson Group’s Harmony Biosciences HRMY Stock Holding History

Janus Henderson Group’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$459K Sell
16,402
-305,893
-95% -$10M ﹤0.01% 2043
2025
Q4 		$12.1M Buy
322,295
+305,893
+1,865% +$10.1M 0.01% 707
2025
Q3 		$452K Hold
16,402
– – ﹤0.01% 2046
2025
Q2 		$518K Sell
16,402
-128,325
-89% -$4.13M ﹤0.01% 1935
2025
Q1 		$4.8M Sell
144,727
-76,336
-35% -$2.74M ﹤0.01% 897
2024
Q4 		$7.61M Buy
221,063
+52,563
+31% +$1.81M ﹤0.01% 785
2024
Q3 		$6.74M Sell
168,500
-9,867
-6% -$347K ﹤0.01% 783
2024
Q2 		$5.38M Sell
178,367
-6,716
-4% -$202K ﹤0.01% 818
2024
Q1 		$6.21M Buy
185,083
+168,434
+1,012% +$5.41M ﹤0.01% 804
2023
Q4 		$538K Sell
16,649
-41
-0.2% -$1.14K ﹤0.01% 1958
2023
Q3 		$547K Buy
16,690
+4
+0% +$139 ﹤0.01% 1876
2023
Q2 		$587K Sell
16,686
-34,691
-68% -$1.2M ﹤0.01% 1890
2023
Q1 		$1.68M Sell
51,377
-1,240,758
-96% -$56.5M ﹤0.01% 1365
2022
Q4 		$71.2M Sell
1,292,135
-222,968
-15% -$12.3M 0.05% 310
2022
Q3 		$67.1M Buy
1,515,103
+89,935
+6% +$4.39M 0.05% 305
2022
Q2 		$69.5M Sell
1,425,168
-179,741
-11% -$8.09M 0.05% 312
2022
Q1 		$78.1M Buy
1,604,909
+61,185
+4% +$2.5M 0.04% 373
2021
Q4 		$65.8M Buy
1,543,724
+324,165
+27% +$12.9M 0.03% 469
2021
Q3 		$46.7M Sell
1,219,559
-41,833
-3% -$1.35M 0.02% 572
2021
Q2 		$35.6M Buy
1,261,392
+107,609
+9% +$3.23M 0.02% 655
2021
Q1 		$38.1M Buy
1,153,783
+59,334
+5% +$2.08M 0.02% 619
2020
Q4 		$39.6M Buy
1,094,449
+219,540
+25% +$8.86M 0.02% 597
2020
Q3 		$29.7M Buy
+874,909
New +$31.9M 0.02% 625

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Janus Henderson Group's HRMY Position: Q1 2026 in Review

Janus Henderson Group reduced its Harmony Biosciences (HRMY) stake by 95% in Q1 2026, selling an estimated $10M and leaving 16,402 shares worth $459K. The position accounts for ﹤0.01% of the portfolio, ranked #2043.

Janus Henderson Group first reported a position in HRMY in Q3 2020 and has held it in 23 quarters since. The position peaked at $78.1M in Q1 2022. 311 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • Janus Henderson Group held 16,402 shares of Harmony Biosciences worth $459K as of Q1 2026.
  • Janus Henderson Group sold 305,893 Harmony Biosciences shares in Q1 2026, an estimated $10M.
  • Harmony Biosciences made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #2043 holding.
  • Janus Henderson Group first reported a position in Harmony Biosciences in Q3 2020 and has held it in 23 quarters since.
  • Janus Henderson Group's Harmony Biosciences position peaked at $78.1M in Q1 2022.
  • 311 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.